Clinical Trial Update: A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy [Phase 4]

View source ↗

Summary

Phase 4 study evaluating add-on pioglitazone or dapagliflozin in type 2 diabetes patients inadequately controlled by a DPP-4 inhibitor and metformin; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Celltrion Pharm, Inc. | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED